Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Pitroda

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
JAMA Oncology|December 28, 2023
Nontumor Cells in Tumor Samples Bias Expression-Based Models-ReplyRohan R Katipally, Sean P Pitroda
Neoplasia (New York, N.Y.)|December 23, 2022
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimizationGreeshma Rajeev-Kumar, Sean P Pitroda
The Journal of Clinical Investigation|March 2, 2026
IFN signaling at the nexus of the radiotherapy response in malignant peripheral nerve sheath tumorsSean P Pitroda, Ralph R Weichselbaum
NPJ Precision Oncology|January 3, 2024
Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockadeLiam F Spurr, Sean P Pitroda
Nature Reviews. Clinical Oncology|May 17, 2019
Integrated molecular and clinical staging defines the spectrum of metastatic cancerSean P Pitroda, Ralph R Weichselbaum
JAMA Oncology|November 20, 2025
Radiotherapy Duality in Metastatic Disease-Inhibiting Seeding, Unmasking DormancySean P Pitroda, Ralph R Weichselbaum
Nature Cancer|February 5, 2022
Immunoradiotherapy goes club(bing)Ralph R Weichselbaum, Sean P Pitroda
International Journal of Radiation Oncology, Biology, Physics|November 18, 2023
Multidisciplinary Collaboration is KeyStanley L Liauw, Sean P Pitroda
Scientific Reports|August 21, 2024
Clinical and molecular correlates of tumor aneuploidy in metastatic non-small cell lung cancerLiam F Spurr, Sean P Pitroda
The Lancet. Oncology|August 1, 2024
Radiotherapy, immunity, and immune checkpoint inhibitorsConnor Lynch, Sean P Pitroda, Ralph R Weichselbaum
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
JAMA Oncology|December 28, 2023
Nontumor Cells in Tumor Samples Bias Expression-Based Models-ReplyRohan R Katipally, Sean P Pitroda
Neoplasia (New York, N.Y.)|December 23, 2022
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimizationGreeshma Rajeev-Kumar, Sean P Pitroda
The Journal of Clinical Investigation|March 2, 2026
IFN signaling at the nexus of the radiotherapy response in malignant peripheral nerve sheath tumorsSean P Pitroda, Ralph R Weichselbaum
NPJ Precision Oncology|January 3, 2024
Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockadeLiam F Spurr, Sean P Pitroda
Nature Reviews. Clinical Oncology|May 17, 2019
Integrated molecular and clinical staging defines the spectrum of metastatic cancerSean P Pitroda, Ralph R Weichselbaum
JAMA Oncology|November 20, 2025
Radiotherapy Duality in Metastatic Disease-Inhibiting Seeding, Unmasking DormancySean P Pitroda, Ralph R Weichselbaum
Nature Cancer|February 5, 2022
Immunoradiotherapy goes club(bing)Ralph R Weichselbaum, Sean P Pitroda
International Journal of Radiation Oncology, Biology, Physics|November 18, 2023
Multidisciplinary Collaboration is KeyStanley L Liauw, Sean P Pitroda
Scientific Reports|August 21, 2024
Clinical and molecular correlates of tumor aneuploidy in metastatic non-small cell lung cancerLiam F Spurr, Sean P Pitroda
The Lancet. Oncology|August 1, 2024
Radiotherapy, immunity, and immune checkpoint inhibitorsConnor Lynch, Sean P Pitroda, Ralph R Weichselbaum
Pageof 9